Found: 47
Select item for more details and to access through your institution.
Microfluidic Platform for Generating and Releasing Patient‐Derived Cancer Organoids with Diverse Shapes: Insight into Shape‐Dependent Tumor Growth.
- Published in:
- Advanced Materials, 2024, v. 36, n. 44, p. 1, doi. 10.1002/adma.202410547
- By:
- Publication type:
- Article
Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33144-9
- By:
- Publication type:
- Article
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 21, p. 2801, doi. 10.1001/jama.289.21.JOC30885
- By:
- Publication type:
- Article
PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer.
- Published in:
- Radiation Oncology, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13014-024-02410-z
- By:
- Publication type:
- Article
Breast cancer immune microenvironment: from pre-clinical models to clinical therapies.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 2, p. 257, doi. 10.1007/s10549-021-06431-0
- By:
- Publication type:
- Article
Novel classes of immunotherapy for breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 1, p. 15, doi. 10.1007/s10549-021-06405-2
- By:
- Publication type:
- Article
Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 169, n. 3, p. 413, doi. 10.1007/s10549-018-4710-5
- By:
- Publication type:
- Article
Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28788-6
- By:
- Publication type:
- Article
Functional variants of OCTN cation transporter genes are associated with Crohn disease.
- Published in:
- Nature Genetics, 2004, v. 36, n. 5, p. 471, doi. 10.1038/ng1339
- By:
- Publication type:
- Article
A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041).
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 1, p. 104, doi. 10.1007/s10637-015-0313-8
- By:
- Publication type:
- Article
Therapeutische Behandlung der minimalen Resterkrankung zur Verhinderung von Spätrezidiven bei Hormonrezeptor-positivem Brustkrebs: Herausforderungen und neue Ansätze.
- Published in:
- Kompass Onkologie, 2022, v. 9, n. 2, p. 55, doi. 10.1159/000524876
- By:
- Publication type:
- Article
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46495-2
- By:
- Publication type:
- Article
Extended Adjuvant Tamoxifen for Early Breast Cancer: A Meta-Analysis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088238
- By:
- Publication type:
- Article
Utility of ctDNA in predicting relapse in solid tumors after curative therapy: a meta-analysis.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 4, p. 1, doi. 10.1093/jncics/pkad040
- By:
- Publication type:
- Article
Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 4, p. N.PAG, doi. 10.1093/jncics/pkz050
- By:
- Publication type:
- Article
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 4, p. N.PAG, doi. 10.1093/jncics/pkz049
- By:
- Publication type:
- Article
Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41523-020-0166-y
- By:
- Publication type:
- Article
If we build it they will come: targeting the immune response to breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0133-7
- By:
- Publication type:
- Article
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0130-x
- By:
- Publication type:
- Article
The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 445, doi. 10.3390/cancers16020445
- By:
- Publication type:
- Article
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 1, p. 159, doi. 10.1007/s10549-017-4580-2
- By:
- Publication type:
- Article
Feasibility of a randomized controlled trial of vitamin D vs. placebo in women with recently diagnosed breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 2, p. 759, doi. 10.1007/s10549-012-2120-7
- By:
- Publication type:
- Article
Seize the engine: Emerging cell cycle targets in breast cancer.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 1, p. 1, doi. 10.1002/ctm2.1544
- By:
- Publication type:
- Article
Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.667397
- By:
- Publication type:
- Article
Barcoded Medication Administration.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
CD2BP1 and CARD15 Mutations Are Not Associated with Pyoderma Gangrenosum in Patients with Inflammatory Bowel Disease.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial.
- Published in:
- British Journal of Cancer, 2019, v. 121, n. 4, p. 318, doi. 10.1038/s41416-019-0517-3
- By:
- Publication type:
- Article
Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Benchmarking to the Gold Standard: Hyaluronan‐Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid Culture.
- Published in:
- Advanced Materials, 2019, v. 31, n. 36, p. N.PAG, doi. 10.1002/adma.201901166
- By:
- Publication type:
- Article
Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies.
- Published in:
- Advanced Healthcare Materials, 2022, v. 11, n. 1, p. 1, doi. 10.1002/adhm.202101085
- By:
- Publication type:
- Article
Author Correction: Gene isoforms as expression-based biomarkers predictive of drug response in vitro.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Gene isoforms as expression-based biomarkers predictive of drug response in vitro.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01153-8
- By:
- Publication type:
- Article
DNA replication stress: a source of APOBEC3B expression in breast cancer.
- Published in:
- Genome Biology, 2016, v. 17, p. 1, doi. 10.1186/s13059-016-1069-y
- By:
- Publication type:
- Article
Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00679-7
- By:
- Publication type:
- Article
The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-34348-0
- By:
- Publication type:
- Article
Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potential.
- Published in:
- Frontiers in Genetics, 2023, v. 14, p. 1, doi. 10.3389/fgene.2023.1086163
- By:
- Publication type:
- Article
Assessing therapy response in patient-derived xenografts.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 620, p. 1, doi. 10.1126/scitranslmed.abf4969
- By:
- Publication type:
- Article
Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11419, doi. 10.3390/ijms241411419
- By:
- Publication type:
- Article
Detection of metabolic adaptation in a triple-negative breast cancer animal model with [<sup>18</sup>F]choline-PET imaging as a surrogate for drug resistance.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1261, doi. 10.1007/s00259-023-06546-0
- By:
- Publication type:
- Article
Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 5, p. 717, doi. 10.1093/jnci/djad240
- By:
- Publication type:
- Article
Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2018, v. 110, n. 1, p. 1, doi. 10.1093/jnci/djx141
- By:
- Publication type:
- Article
Association of MDM2 T309 G and p53 Arg72 Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 9, p. 1482, doi. 10.1111/jgh.12286
- By:
- Publication type:
- Article
Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29 , 9891–9895"
- Published in:
- Current Oncology, 2023, v. 30, n. 5, p. 5050, doi. 10.3390/curroncol30050381
- By:
- Publication type:
- Article
Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain.
- Published in:
- Current Oncology, 2022, v. 29, n. 12, p. 9891, doi. 10.3390/curroncol29120778
- By:
- Publication type:
- Article
Discoloration of skin and urine after treatment with hydroxocobalamin for cyanide poisoning.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2009, v. 180, n. 2, p. 251, doi. 10.1503/cmaj.080727
- By:
- Publication type:
- Article
Bowel loops and eyelid droops.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2008, v. 179, n. 9, p. 927, doi. 10.1503/cmaj.080651
- By:
- Publication type:
- Article